Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM).
暂无分享,去创建一个
G. Launoy | J. Faivre | P. Arveux | J. Estève | X. Troussard | A. Guizard | B. Trétarre | P. Grosclaude | E. Sauleau | A. Bouvier | L. Remontet | P. Carli | M. Colonna | M. Velten | C. Schvartz | M. Maynadié | F. Molinié | N. Bossard | A. Belot | N. Maarouf | C. Bessaguet | A. Jaffré | A. Danzon | N. Bourdon-Raverdy | P. Carli | M. Maynadie | Jean Faivre | Xavier Troussard | Jacques Estève | A. Guizard
[1] J. Estève,et al. An overall strategy based on regression models to estimate relative survival and model the effects of prognostic factors in cancer survival studies , 2007, Statistics in medicine.
[2] J. Smith,et al. Influence of sex on lung cancer histology, stage, and survival in a midwestern United States tumor registry. , 2005, Clinical lung cancer.
[3] G. Vlastos,et al. Modeling the effect of age in T1-2 breast cancer using the SEER database , 2005, BMC Cancer.
[4] J. Faivre,et al. Time trends in the treatment and survival of recurrences from colorectal cancer. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] N. Rioux-Leclercq,et al. Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience , 2005 .
[6] G. Hédelin,et al. Non-small-cell lung cancer in a French department, (1982–1997): management and outcome , 2005, British Journal of Cancer.
[7] Mike Quinn,et al. Standard cancer patient population for age standardising survival ratios. , 2004, European journal of cancer.
[8] Paul W Dickman,et al. Regression models for relative survival , 2004, Statistics in medicine.
[9] G. Hédelin,et al. Survival of women with breast cancer in France: variation with age, stage and treatment , 2001, Breast Cancer Research and Treatment.
[10] F. Berrino,et al. Variations in survival for invasive cervical cancer among European women, 1978–89 , 1999, Cancer Causes & Control.
[11] M. Coleman,et al. Survival of cancer patients in europe—The EUROCARE study , 1995, Cancer Causes & Control.
[12] F. Khuri,et al. Sex differences in survival in non-small cell lung cancer patients 1974-1998. , 2004, Acta oncologica.
[13] Jarrett Rosenberg,et al. The effect of age, race, tumor size, tumor grade, and disease stage on invasive ductal breast cancer survival in the U.S. SEER database , 2004, Breast Cancer Research and Treatment.
[14] E Carrani,et al. The EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysis. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[15] M. Coleman,et al. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[16] G. Hédelin,et al. Cancer incidence and mortality in France over the period 1978-2000. , 2003, Revue d'epidemiologie et de sante publique.
[17] P. Arveux,et al. Incidence of thyroid cancer in adults recorded by French cancer registries (1978-1997). , 2002, European journal of cancer.
[18] C. Faivre-Finn,et al. Colon cancer in France: evidence for improvement in management and survival , 2002, Gut.
[19] Hermann Brenner,et al. Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland. , 2002, International journal of epidemiology.
[20] G. Launoy,et al. Evidence of improving survival of patients with rectal cancer in France: a population based study , 1999, Gut.
[21] T. Hakulinen,et al. Mixture models for cancer survival analysis: application to population-based data with covariates. , 1999, Statistics in medicine.
[22] J. Estève,et al. Relative survival and the estimation of net survival: elements for further discussion. , 1990, Statistics in medicine.
[23] T. Hakulinen,et al. Cancer survival corrected for heterogeneity in patient withdrawal. , 1982, Biometrics.